CAS 110140-89-1
:Ridogrel
Description:
Ridogrel is a chemical compound that functions primarily as an antiplatelet agent, which means it inhibits platelet aggregation and is used in the management of cardiovascular diseases. It is classified as a dual inhibitor of thromboxane A2 synthesis and platelet activation, making it effective in preventing thrombus formation. Ridogrel exhibits a unique mechanism of action by blocking the thromboxane receptor and inhibiting the enzyme responsible for thromboxane production. This dual action contributes to its therapeutic efficacy in reducing the risk of cardiovascular events. The compound is typically administered in a specific dosage form, and its pharmacokinetics involve absorption, distribution, metabolism, and excretion processes that are crucial for its effectiveness and safety profile. Ridogrel's chemical structure includes functional groups that contribute to its biological activity, and it is subject to regulatory scrutiny to ensure its safety and efficacy in clinical use. As with any medication, potential side effects and contraindications should be considered when evaluating its use in patients.
Formula:C18H17F3N2O3
InChI:InChI=1/C18H17F3N2O3/c19-18(20,21)15-7-3-5-13(11-15)17(14-6-4-9-22-12-14)23-26-10-2-1-8-16(24)25/h3-7,9,11-12H,1-2,8,10H2,(H,24,25)/b23-17-
InChI key:InChIKey=GLLPUTYLZIKEGF-HAVVHWLPSA-N
SMILES:C(=N\OCCCCC(O)=O)(\C1=CC(C(F)(F)F)=CC=C1)/C=2C=CC=NC2
Synonyms:- Ridogrel
- Pentanoic acid, 5-[[(E)-[3-pyridinyl[3-(trifluoromethyl)phenyl]methylene]amino]oxy]-
- R 68070
- Pentanoic acid, 5-[[[3-pyridinyl[3-(trifluoromethyl)phenyl]methylene]amino]oxy]-, (E)-
- Ridogrel [USAN:INN:BAN]
- (E)-5-(((alpha-3-Pyridyl-m-(trifluoromethyl)benzylidene)amino)oxy)valeric acid
- Ridogrelum
- Ridogrelum [INN-Latin]
- Pentanoic acid, 5-(((3-pyridinyl(3-(trifluoromethyl)phenyl)methylene)amino)oxy)-, (E)-
- 5-[({(1Z)-pyridin-3-yl[3-(trifluoromethyl)phenyl]methylidene}amino)oxy]pentanoic acid
- 5-[({(1E)-pyridin-3-yl[3-(trifluoromethyl)phenyl]methylidene}amino)oxy]pentanoic acid
- 5-[[(E)-[3-Pyridinyl[3-(trifluoromethyl)phenyl]methylene]amino]oxy]pentanoic acid
- R 68070
- 5-[[pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypenta noic acid
- 5-[[(E)-(3-Pyridinyl)[3-(trifluoromethyl)phenyl]methylene]aminooxy]valeric acid
- R70416
- R-70416
- R 70416
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Ridogrel
CAS:<p>Ridogrel is a synthetic prodrug that is hydrolyzed in vivo to the active form, ticagrelor. Ticagrelor is an antiplatelet drug that inhibits adenosine diphosphate (ADP) and thromboxane A2 (TXA2), substances that are involved in platelet aggregation. Ridogrel has been shown to have activity index values of >0.5 for inflammatory bowel disease and experimental models of colitis. Ridogrel has been shown to be biocompatible with a polymer scaffold and does not show significant thermal expansion or change in physical properties after being placed in an environment mimicking the human body for 30 days. This drug has also been shown to increase the patency of a segment of bowel during experimental models of bowel disease.</p>Formula:C18H17F3N2O3Purity:Min. 95%Molecular weight:366.3 g/mol
